Pnc Financial Services Group, Inc. Heron Therapeutics, Inc. Transaction History

Pnc Financial Services Group, Inc.

  • $148 Billion
  • Q4 2024

A detailed history of Pnc Financial Services Group, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 117 shares of HRTX stock, worth $278. This represents 0.0% of its overall portfolio holdings.

Number of Shares
117
Previous 117 -0.0%
Holding current value
$278
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024
SELL
$1.71 - $3.06 $2,565 - $4,590
-1,500 Reduced 92.76%
117 $0
Q4 2023

Feb 09, 2024
SELL
$0.54 - $1.82 $49 - $165
-91 Reduced 5.33%
1,617 $2,000
Q4 2022

Feb 10, 2023
SELL
$2.25 - $4.67 $900 - $1,868
-400 Reduced 18.98%
1,708 $4,000
Q2 2022

Aug 12, 2022
SELL
$2.3 - $6.29 $673 - $1,842
-293 Reduced 12.2%
2,108 $5,000
Q1 2022

May 12, 2022
BUY
$4.63 - $9.94 $3,208 - $6,888
693 Added 40.57%
2,401 $13,000
Q3 2021

Nov 05, 2021
SELL
$10.13 - $15.0 $33,347 - $49,380
-3,292 Reduced 65.84%
1,708 $18,000
Q2 2021

Aug 06, 2021
BUY
$13.27 - $18.48 $15,778 - $21,972
1,189 Added 31.2%
5,000 $77,000
Q1 2021

May 07, 2021
BUY
$14.49 - $20.72 $1,318 - $1,885
91 Added 2.45%
3,811 $61,000
Q4 2020

Feb 12, 2021
SELL
$14.61 - $22.14 $10,066 - $15,254
-689 Reduced 15.63%
3,720 $78,000
Q3 2020

Nov 06, 2020
BUY
$13.67 - $17.77 $3,731 - $4,851
273 Added 6.6%
4,409 $65,000
Q2 2020

Aug 07, 2020
BUY
$10.89 - $21.47 $15,659 - $30,873
1,438 Added 53.3%
4,136 $60,000
Q1 2020

May 08, 2020
BUY
$10.23 - $24.56 $21,114 - $50,691
2,064 Added 325.55%
2,698 $31,000
Q4 2019

Feb 07, 2020
SELL
$17.42 - $26.61 $3,344 - $5,109
-192 Reduced 23.24%
634 $14,000
Q3 2019

Nov 08, 2019
BUY
$16.36 - $21.39 $3,010 - $3,935
184 Added 28.66%
826 $15,000
Q2 2019

Aug 09, 2019
SELL
$16.93 - $26.22 $1.24 Million - $1.92 Million
-73,106 Reduced 99.13%
642 $0
Q1 2019

May 10, 2019
BUY
$23.15 - $28.34 $621,971 - $761,410
26,867 Added 57.31%
73,748 $0
Q4 2018

Feb 08, 2019
SELL
$22.03 - $32.01 $51,351 - $74,615
-2,331 Reduced 4.74%
46,881 $1.22 Million
Q3 2018

Nov 09, 2018
BUY
$30.0 - $40.85 $12,570 - $17,116
419 Added 0.86%
49,212 $0
Q2 2018

Aug 10, 2018
BUY
$26.4 - $42.0 $1.29 Million - $2.05 Million
48,793 New
48,793 $0
Q4 2017

Feb 09, 2018
SELL
$14.8 - $18.85 $22,200 - $28,275
-1,500 Closed
0 $0
Q3 2017

Nov 13, 2017
BUY
$14.65 - $16.85 $21,975 - $25,275
1,500
1,500 $0

Others Institutions Holding HRTX

# of Institutions
172
Shares Held
114M
Call Options Held
2M
Put Options Held
32.4K
View Full List

About HERON THERAPEUTICS, INC.

HRTX Quotes by TradingView
  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $283M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email